These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
79 related articles for article (PubMed ID: 1306981)
1. "Cocktail" therapy for acute pancreatitis: combined therapy of protease inhibitor, xanthine oxidase inhibitor and platelet activating factor antagonist in rat caerulein-induced pancreatis. Hirano T; Manabe T Nihon Geka Hokan; 1992 Nov; 61(6):433-44. PubMed ID: 1306981 [TBL] [Abstract][Full Text] [Related]
2. Protective effects of combined therapy with a protease inhibitor, ONO 3307, and a xanthine oxidase inhibitor, allopurinol on temporary ischaemic model of pancreatitis in rats. Hirano T; Manabe T; Ohshio G; Nio Y Nihon Geka Hokan; 1992 May; 61(3):224-33. PubMed ID: 1444702 [TBL] [Abstract][Full Text] [Related]
3. Platelet activating factor (PAF) inhibitor (TCV-309) reduces caerulein- and PAF-induced pancreatitis. A morphologic and functional study in the rat. Tomaszewska R; Dembiński A; Warzecha Z; Banaś M; Konturek SJ; Stachura J J Physiol Pharmacol; 1992 Dec; 43(4):345-52. PubMed ID: 1294265 [TBL] [Abstract][Full Text] [Related]
4. Protective effects of therapy with a protease and xanthine oxidase inhibitor in short form pancreatic biliary obstruction and ischemia in rats. Hirano T; Manabe T; Steer M; Printz H; Calne R; Tobe T Surg Gynecol Obstet; 1993 Apr; 176(4):371-81. PubMed ID: 8460415 [TBL] [Abstract][Full Text] [Related]
5. A new synthetic protease inhibitor, E-3123, reduces organelle fragility of acinar cells in rat caerulein pancreatitis. Hirano T; Manabe T; Imanishi K; Yotsumoto F; Kyogoku T; Tobe T Nihon Geka Hokan; 1991 Nov; 60(6):406-14. PubMed ID: 1820013 [TBL] [Abstract][Full Text] [Related]
6. Protective effect of nafamostat mesilate on cellular and lysosomal fragility of acinar cells in rat cerulein pancreatitis. Manabe T; Hirano T; Imanishi K; Ando K; Yotsumoto F; Tobe T Int J Pancreatol; 1992 Oct; 12(2):167-72. PubMed ID: 1281204 [TBL] [Abstract][Full Text] [Related]
7. Protective effect of gabexate mesilate (FOY) against pancreatic injuries induced by ethanol in rats. Hirano T Nihon Geka Hokan; 1994 Jan; 63(1):10-20. PubMed ID: 7826181 [TBL] [Abstract][Full Text] [Related]
8. Ghrelin attenuates the development of acute pancreatitis in rat. Dembinski A; Warzecha Z; Ceranowicz P; Tomaszewska R; Stachura J; Konturek SJ; Konturek PC J Physiol Pharmacol; 2003 Dec; 54(4):561-73. PubMed ID: 14726611 [TBL] [Abstract][Full Text] [Related]
9. Effect of platelet-activating factor antagonist WEB 2086 on microcirculatory disorders in acute experimental pancreatitis of graded severity. Mann O; Tiefenbacher WJ; Kaifi J; Schneider C; Kluth D; Bloechle C; Yekebas E; Izbicki JR; Strate T Pancreas; 2009 Jan; 38(1):58-64. PubMed ID: 18695628 [TBL] [Abstract][Full Text] [Related]
10. Effect of prostaglandin E on the redistribution of lysosomal enzymes in caerulein-induced pancreatitis. Hirano T; Manabe T; Yotsumoto F; Ando K; Imanishi K; Tobe T Hepatogastroenterology; 1993 Apr; 40(2):155-8. PubMed ID: 7685311 [TBL] [Abstract][Full Text] [Related]
11. IGF-1 stimulates production of interleukin-10 and inhibits development of caerulein-induced pancreatitis. Warzecha Z; Dembinski A; Ceranowicz P; Konturek SJ; Tomaszewska R; Stachura J; Konturek PC J Physiol Pharmacol; 2003 Dec; 54(4):575-90. PubMed ID: 14726612 [TBL] [Abstract][Full Text] [Related]
12. Role of endogenous platelet-activating factor in caerulein-induced acute pancreatitis in rats: protective effects of a PAF-antagonist. Fujimura K; Kubota Y; Ogura M; Yamaguchi T; Binnaka T; Tani K; Kitagawa S; Mizuno T; Inoue K J Gastroenterol Hepatol; 1992; 7(2):199-202. PubMed ID: 1571504 [TBL] [Abstract][Full Text] [Related]
13. The role of adenosine receptors for pancreatic blood flow in caerulein-induced acute pancreatitis. Celiński K; Szczerbiński M; Słomka M; Kasztelan-Szczerbińska B Rocz Akad Med Bialymst; 2003; 48():57-60. PubMed ID: 14737942 [TBL] [Abstract][Full Text] [Related]
14. Combined therapy of a cephalosporin, Shiomarin and a new potent protease inhibitor, E3123 in rat taurocholate-induced pancreatitis. Hirano T; Manabe T Nihon Geka Hokan; 1992 Nov; 61(6):423-32. PubMed ID: 1306980 [TBL] [Abstract][Full Text] [Related]
15. Influence of adenosine receptors on the development of caerulein-induced acute pancreatitis. Szczerbiński M; Celiński K; Słomka M; Kasztelan-Szczerbińska B; Cichoz-Lach H Ann Univ Mariae Curie Sklodowska Med; 2002; 57(1):245-56. PubMed ID: 12898930 [TBL] [Abstract][Full Text] [Related]
16. Protection by gabexate mesilate (FOY) of the exocrine pancreas in rats with acute pancreatitis induced by a supramaximal dose of caerulein. Hirano T; Manabe T; Tobe T J Gastroenterol Hepatol; 1991; 6(3):260-4. PubMed ID: 1717033 [TBL] [Abstract][Full Text] [Related]
18. Effect of prostaglandin E2 on cellular, lysosomal and mitochondrial fragility in caerulein-induced pancreatitis in rats. Manabe T; Hirano T; Ando K; Yotsumoto F; Tobe T Hepatogastroenterology; 1993 Oct; 40(5):463-6. PubMed ID: 8270235 [TBL] [Abstract][Full Text] [Related]
19. Effects of loxiglumide on experimental acute pancreatitis in comparison with gabexate mesilate. Kimura K; Tominaga K; Fujii M; Saito T; Kasai H Arzneimittelforschung; 1998 Jan; 48(1):65-9. PubMed ID: 9522035 [TBL] [Abstract][Full Text] [Related]
20. Protective effects of gabexate mesilate (FOY) against impaired pancreatic energy metabolism in rat acute pancreatitis induced by caerulein. Hirano T; Manabe T; Tobe T Life Sci; 1991; 49(22):PL179-84. PubMed ID: 1719326 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]